| _version_ |
1848760217001525248
|
| author |
Chan, Arlene
|
| author_facet |
Chan, Arlene
|
| author_sort |
Chan, Arlene
|
| building |
Curtin Institutional Repository
|
| collection |
Online Access
|
| first_indexed |
2025-11-14T10:12:16Z
|
| format |
Journal Article
|
| id |
curtin-20.500.11937-58267
|
| institution |
Curtin University Malaysia
|
| institution_category |
Local University
|
| last_indexed |
2025-11-14T10:12:16Z
|
| publishDate |
2017
|
| recordtype |
eprints
|
| repository_type |
Digital Repository
|
| spelling |
curtin-20.500.11937-582672018-12-14T00:58:12Z Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits? Chan, Arlene 2017 Journal Article http://hdl.handle.net/20.500.11937/58267 10.21037/cco.2017.10.03 restricted
|
| spellingShingle |
Chan, Arlene
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
|
| title |
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
|
| title_full |
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
|
| title_fullStr |
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
|
| title_full_unstemmed |
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
|
| title_short |
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
|
| title_sort |
trastuzumab biosimilar in early breast cancer setting: will there be direct patient benefits?
|
| url |
http://hdl.handle.net/20.500.11937/58267
|